Randomised clinical trial: yoga vs a low-FODMAP diet in patients with irritable bowel syndrome.
Study Goal
The researchers aimed to compare the effects of a low-FODMAP diet versus yoga on gastrointestinal symptoms and quality of life in patients with irritable bowel syndrome.
Results Summary
The low-FODMAP diet showed statistically significant within-group improvements in gastrointestinal symptoms and quality of life at 12 and 24 weeks, with no significant difference compared to yoga. Adverse events were rare and comparable between groups.
Population
Patients with irritable bowel syndrome (n=59).
Effective Dosage
Three sessions of nutritional counseling over 12 weeks.
Duration
12 weeks.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
yoga-based intervention | decrease | gastrointestinal symptoms (IBS-SSS) | patients with irritable bowel syndrome | all P < .001 | showed statistically significant effects | #1 |
low-FODMAP diet | decrease | gastrointestinal symptoms (IBS-SSS) | patients with irritable bowel syndrome | all P < .001 | showed statistically significant effects | #2 |
yoga-based intervention | increase | quality of life (IBS-QOL) | patients with irritable bowel syndrome | - | showed comparable within-group effects | #3 |
low-FODMAP diet | increase | quality of life (IBS-QOL) | patients with irritable bowel syndrome | - | showed comparable within-group effects | #4 |
yoga-based intervention | increase | health (SF-36) | patients with irritable bowel syndrome | - | showed comparable within-group effects | #5 |
low-FODMAP diet | increase | health (SF-36) | patients with irritable bowel syndrome | - | showed comparable within-group effects | #6 |
yoga-based intervention | decrease | perceived stress (CPSS, PSQ) | patients with irritable bowel syndrome | - | showed comparable within-group effects | #7 |
low-FODMAP diet | decrease | perceived stress (CPSS, PSQ) | patients with irritable bowel syndrome | - | showed comparable within-group effects | #8 |
yoga-based intervention | increase | body awareness (BAQ) | patients with irritable bowel syndrome | - | showed comparable within-group effects | #9 |
low-FODMAP diet | increase | body awareness (BAQ) | patients with irritable bowel syndrome | - | showed comparable within-group effects | #10 |
yoga-based intervention | increase | body responsiveness (BRS) | patients with irritable bowel syndrome | - | showed comparable within-group effects | #11 |
low-FODMAP diet | increase | body responsiveness (BRS) | patients with irritable bowel syndrome | - | showed comparable within-group effects | #12 |
yoga-based intervention | no change | safety of the interventions | patients with irritable bowel syndrome | One patient | experienced serious adverse events | #13 |
low-FODMAP diet | no change | safety of the interventions | patients with irritable bowel syndrome | One patient | experienced serious adverse events | #14 |
yoga-based intervention | no change | safety of the interventions | patients with irritable bowel syndrome | another, also in each group | experienced nonserious adverse events | #15 |
low-FODMAP diet | no change | safety of the interventions | patients with irritable bowel syndrome | another, also in each group | experienced nonserious adverse events | #16 |
yoga-based intervention | no change | gastrointestinal symptoms (IBS-SSS) score | patients with irritable bowel syndrome | Δ = 31.80; 95%CI = -11.90, 75.50; P = .151 | no statistically significant difference was found between the intervention groups | #17 |
low-FODMAP diet | no change | gastrointestinal symptoms (IBS-SSS) score | patients with irritable bowel syndrome | Δ = 31.80; 95%CI = -11.90, 75.50; P = .151 | no statistically significant difference was found between the intervention groups | #18 |
BACKGROUND: Irritable bowel syndrome is the most frequent gastrointestinal disorder. It is assumed that lifestyle interventions might be a rational treatment approach. AIM: To examine the effect of a yoga-based intervention vs a low-FODMAP diet on patients with irritable bowel syndrome. METHODS: Fifty-nine patients with irritable bowel syndrome undertook a single-blind, randomised controlled trial involving yoga or a low-FODMAP diet for 12 weeks. Patients in the yoga group received two sessions weekly, while patients in the low-FODMAP group received a total of three sessions of nutritional counselling. The primary outcome was a change in gastrointestinal symptoms (IBS-SSS). Secondary outcomes explored changes in quality of life (IBS-QOL), health (SF-36), perceived stress (CPSS, PSQ), body awareness (BAQ), body responsiveness (BRS) and safety of the interventions. Outcomes were examined in weeks 12 and 24 by assessors "blinded" to patients' group allocation. RESULTS: No statistically significant difference was found between the intervention groups, with regard to IBS-SSS score, at either 12 (Δ = 31.80; 95%CI = -11.90, 75.50; P = .151) or 24 weeks (Δ = 33.41; 95%CI = -4.21, 71.04; P = .081). Within-group comparisons showed statistically significant effects for yoga and low-FODMAP diet at both 12 and 24 weeks (all P < .001). Comparable within-group effects occurred for the other outcomes. One patient in each intervention group experienced serious adverse events (P = 1.00) and another, also in each group, experienced nonserious adverse events (P = 1.00). CONCLUSIONS: Patients with irritable bowel syndrome might benefit from yoga and a low-FODMAP diet, as both groups showed a reduction in gastrointestinal symptoms. More research on the underlying mechanisms of both interventions is warranted, as well as exploration of potential benefits from their combined use.